72 related articles for article (PubMed ID: 22855545)
1. Favorable effect of sorafenib in a patient with neurofibromatosis-associated pulmonary hypertension.
Tamura Y; Ono T; Sano M; Fukuda K; Kataoka M; Satoh T
Am J Respir Crit Care Med; 2012 Aug; 186(3):291-2. PubMed ID: 22855545
[No Abstract] [Full Text] [Related]
2. Receptor tyrosine kinase inhibitors in rodent pulmonary hypertension.
Moreno-Vinasco L; Garcia JG
Adv Exp Med Biol; 2010; 661():419-34. PubMed ID: 20204746
[TBL] [Abstract][Full Text] [Related]
3. 18F-Fluorodeoxyglucose positron emission tomography for monitoring response to sorafenib treatment in patients with hepatocellular carcinoma.
Siemerink EJ; Mulder NH; Brouwers AH; Hospers GA
Oncologist; 2008 Jun; 13(6):734-5; author reply 736-7. PubMed ID: 18586929
[No Abstract] [Full Text] [Related]
4. Sorafenib - a small molecule with big promise?
Tadmor T; Tallman MS; Polliack A
Leuk Lymphoma; 2010 Feb; 51(2):181-2. PubMed ID: 20001865
[No Abstract] [Full Text] [Related]
5. Long lasting response to the multikinase inhibitor bay 43-9006 (Sorafenib) in a heavily pretreated metastatic thymic carcinoma.
Bisagni G; Rossi G; Cavazza A; Sartori G; Gardini G; Boni C
J Thorac Oncol; 2009 Jun; 4(6):773-5. PubMed ID: 19461405
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.
Cheng AL; Kang YK; Chen Z; Tsao CJ; Qin S; Kim JS; Luo R; Feng J; Ye S; Yang TS; Xu J; Sun Y; Liang H; Liu J; Wang J; Tak WY; Pan H; Burock K; Zou J; Voliotis D; Guan Z
Lancet Oncol; 2009 Jan; 10(1):25-34. PubMed ID: 19095497
[TBL] [Abstract][Full Text] [Related]
7. Targeting B-Raf as a treatment strategy for polycystic kidney disease.
Sas KM
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F942-3. PubMed ID: 20810617
[No Abstract] [Full Text] [Related]
8. Diagnosis and management of leptomeningeal disease.
Walker JG
Clin J Oncol Nurs; 2009 Aug; 13(4):384-7. PubMed ID: 19648093
[No Abstract] [Full Text] [Related]
9. Sustained remission with the kinase inhibitor sorafenib in stage IV metastatic adrenocortical carcinoma.
Butler C; Butler WM; Rizvi AA
Endocr Pract; 2010; 16(3):441-5. PubMed ID: 20061282
[TBL] [Abstract][Full Text] [Related]
10. Current status of molecularly targeted drugs for the treatment of advanced thyroid cancer.
Takami HE
Endocr J; 2011; 58(3):151-3. PubMed ID: 21383525
[TBL] [Abstract][Full Text] [Related]
11. Parenchymal versus nonparenchymal target lesion response in clinical trials for metastatic medullary thyroid cancer.
Machens A; Dralle H
J Clin Oncol; 2010 Oct; 28(28):e534: author reply e535-6. PubMed ID: 20713862
[No Abstract] [Full Text] [Related]
12. The effect of sorafenib in postoperative adhesion formation in a rat uterine horn model.
Boztosun A; Ozer H; Altun A; Kiliçkap S; Gulturk S; Müderris II; Yanik A
Clin Exp Obstet Gynecol; 2012; 39(3):351-5. PubMed ID: 23157042
[TBL] [Abstract][Full Text] [Related]
13. Sorafenib-induced pancreatitis.
Amar S; Wu KJ; Tan WW
Mayo Clin Proc; 2007 Apr; 82(4):521. PubMed ID: 17418082
[No Abstract] [Full Text] [Related]
14. A pilot study of adjuvant doxorubicin and cyclophosphamide followed by paclitaxel and sorafenib in women with node-positive or high-risk early-stage breast cancer.
Spigel DR; Hainsworth JD; Burris HA; Molthrop DC; Peacock N; Kommor M; Vazquez ER; Greco FA; Yardley DA
Clin Adv Hematol Oncol; 2011 Apr; 9(4):280-6. PubMed ID: 21558987
[TBL] [Abstract][Full Text] [Related]
15. [Sorafenib].
Hansen A; Eschenhagen T
Dtsch Med Wochenschr; 2010 Sep; 135(37):1819-22. PubMed ID: 20730706
[No Abstract] [Full Text] [Related]
16. Sorafenib is effective in the treatment of pulmonary veno-occlusive disease.
Kataoka M; Yanagisawa R; Fukuda K; Yoshino H; Satoh T
Cardiology; 2012; 123(3):172-4. PubMed ID: 23128832
[TBL] [Abstract][Full Text] [Related]
17. Dramatic reduction of chronic lymphoedema of the lower limb with sorafenib therapy.
Moncrieff M; Shannon K; Hong A; Hersey P; Thompson J
Melanoma Res; 2008 Apr; 18(2):161-2. PubMed ID: 18337654
[TBL] [Abstract][Full Text] [Related]
18. Clinical overview of sorafenib in breast cancer.
Moreno-Aspitia A
Future Oncol; 2010 May; 6(5):655-63. PubMed ID: 20465381
[TBL] [Abstract][Full Text] [Related]
19. Drug therapy: sorafenib.
Finn RS
Hepatology; 2010 May; 51(5):1843-9. PubMed ID: 20432260
[No Abstract] [Full Text] [Related]
20. The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma--a pilot study.
Pinter M; Sieghart W; Reiberger T; Rohr-Udilova N; Ferlitsch A; Peck-Radosavljevic M
Aliment Pharmacol Ther; 2012 Jan; 35(1):83-91. PubMed ID: 22032637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
